<P>This book summarizes our current knowledge of MDS, from very basic aspects to the clinical management. It provides guidance to the diagnosis, an understanding of disease mechanisms, and a discussion of treatment strategies.</P>
Myelodysplastic Syndromes (Hematologic Malignancies)
β Scribed by H.J. Deeg D.T. Bowen S.D. Gore T. Haferlach M.M. Le Beau C. Niemeyer
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Leaves
- 142
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
This book summarizes our current knowledge of MDS, from very basic aspects to the clinical management. It provides guidance to the diagnosis, an understanding of disease mechanisms, and a discussion of treatment strategies.
π SIMILAR VOLUMES
<p><span>This book summarizes our current knowledge of MDS, from very basic aspects to the clinical management. It provides guidance to the diagnosis, an understanding of disease mechanisms, and a discussion of treatment strategies.</span></p>
<p><p><b>The diagnosis of myelodysplastic syndromes (MDS), a heterogeneous group of clonal hematopoietic disorders, is being made with increasing frequency over the past decade owing to increased recognition, improved understanding, and an aging population. This book, completely updated since the fi
The myelodysplastic syndromes pose important clinical and scientific challenges which in recent years have attracted growing interest within haemato-oncology and molecular genetics. Their potential as a model for the study of human leukaemogenesis makes this one of the most exciting fields in contem
<p><p>This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the mo
<p><p>Myelodysplastic syndromes (MDS) are the most common hematological malignancies involving mostly the elderly population. The major morbidity relates to patientsβ symptomatic cytopenias.MDS was previously named as βpreleukemia β or β smoldering leukemiaβ as the lack of terminal cells in MDS and